Genomma Approaches Domestic Bond Debut

Genomma Approaches Domestic Bond Debut

Mexico Bonds

Genomma Lab is targeting Thursday for the sale of up to MXP2.0bn ($157m) in what would be the Mexican pharmaceutical and hygiene products company’s domestic bond debut, according to people following the sale. It plans a 10-year fixed-rate note. Proce

Already have an account?

Free trial

Take a free two-week trial now for the latest news, data and market analysis.

Free Trial